Figure 4From: Pathology of rituximab-induced Kaposi sarcoma flareComparison of the inflammatory component between control (left) and KS flare (right) specimens. Both lesions exhibit admixed T-cells (CD3), whereas only the KS flare tumor has a complete absence of B-cells (CD20).Back to article page